Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway

Fig. 1

Mir-30b-5p is significantly down-regulated in thyroid carcinoma and is related to the progression of thyroid cancer. A Analysis of mir-30b-5p expression levels in papillary thyroid carcinoma using TCGA data. B Quantitative RT-PCR was used to detect the relative expression of mir-30b-5p in 60 paired papillary thyroid carcinoma tissues and paired normal tissues. C The relative expression level of mir-30b-5p in T1 stage, T2 stage and T3 stage of papillary thyroid carcinoma patients. D There was a significant difference in the expression of mir-30b-5p in papillary thyroid carcinoma patients with or without lymph node metastasis. E The relative expression level of mir-30b-5p in papillary thyroid carcinoma patient with stage I and stage II. F The relative expression of mir-30b-5p in 4 thyroid cancer cell lines and immortalized normal thyroid epithelial cell line Nthyr-ori-3-1 was analyzed by qRT-PCR. Data are presented as the mean ± SD (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001)

Back to article page